about
Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Antitubercular therapy in patients with cirrhosis: challenges and optionsEffect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in ChinaThe role of delamanid in the treatment of drug-resistant tuberculosis.The effect of tuberculosis on the mortality of cirrhotic patients: a population-based 3-year follow-up studyImpact and safety of endoscopic ultrasound guided fine needle aspiration on patients with cirrhosis and pyrexia of unknown origin in India.A guide to the management of tuberculosis in patients with chronic liver disease.Drug-induced liver injury: a summary of recent advances.Prescribing medications in patients with decompensated liver cirrhosis.Isoniazid: A Review of Characteristics, Properties and Analytical Methods.Answers to multiple choice questions.Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.Prevalence, risk factors, management, and treatment outcomes of first-line antituberculous drug-induced liver injury: a prospective cohort study.Metabolomics of Hydrazine-Induced Hepatotoxicity in Rats for Discovering Potential Biomarkers.
P2860
Q30277969-5AF4390E-A3C5-46A2-9A86-7DEEC43046D0Q33626827-C95ABF3F-D597-4207-B19C-DECD272BC6F1Q34308979-0284EB4C-8C26-4253-9626-934C0BE9E1F4Q35624245-57404F19-C6C9-45F3-935E-26276762890FQ36153859-859BFA92-ABB9-481A-8D0C-E91EDD951E82Q37259954-6143CF4F-9C1E-401D-BF31-9456EF415F21Q37613934-2032DBDD-3D76-4902-958C-482651383D68Q37867695-AB5BAF9B-F5D2-4677-8D96-48B70D1C7363Q38345809-00C7A8C9-4D18-4043-B4C3-4BE96A0A18B5Q39083469-FF77C01F-285F-4CC8-9EDD-572461F72DB1Q42426062-696F3386-9EA1-436C-83B0-58F947CE6474Q45909196-AD8E9ABE-BAFD-4B6D-B034-09DF58E701AFQ51032704-18886766-0BF6-48F9-A192-4DE38F74BA54Q51542639-F29E8F99-B073-44D6-8A58-0FCC37AECDC8Q54969000-A26F8824-FACB-48CC-850E-CFEDC28F985E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatotoxic effects of therapies for tuberculosis.
@en
Hepatotoxic effects of therapies for tuberculosis.
@nl
type
label
Hepatotoxic effects of therapies for tuberculosis.
@en
Hepatotoxic effects of therapies for tuberculosis.
@nl
prefLabel
Hepatotoxic effects of therapies for tuberculosis.
@en
Hepatotoxic effects of therapies for tuberculosis.
@nl
P2093
P2860
P1476
Hepatotoxic effects of therapies for tuberculosis.
@en
P2093
Bahaa E Senousy
Peter V Draganov
Sanaa I Belal
P2860
P2888
P304
P356
10.1038/NRGASTRO.2010.134
P407
P577
2010-08-31T00:00:00Z